NM_016156.6:c.1855T>C

Variant summary

Our verdict is Benign. The variant received -13 ACMG points: 0P and 13B. BP4_StrongBP6BS1BS2

The NM_016156.6(MTMR2):​c.1855T>C​(p.Ser619Pro) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00212 in 1,613,144 control chromosomes in the GnomAD database, including 24 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. S619C) has been classified as Uncertain significance.

Frequency

Genomes: š‘“ 0.0020 ( 2 hom., cov: 32)
Exomes š‘“: 0.0021 ( 22 hom. )

Consequence

MTMR2
NM_016156.6 missense

Scores

8
10

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:1B:9

Conservation

PhyloP100: 1.28

Publications

4 publications found
Variant links:
Genes affected
MTMR2 (HGNC:7450): (myotubularin related protein 2) This gene is a member of the myotubularin family of phosphoinositide lipid phosphatases. The encoded protein possesses phosphatase activity towards phosphatidylinositol-3-phosphate and phosphatidylinositol-3,5-bisphosphate. Mutations in this gene are a cause of Charcot-Marie-Tooth disease type 4B, an autosomal recessive demyelinating neuropathy. Alternatively spliced transcript variants encoding multiple isoforms have been found for this gene. [provided by RefSeq, Aug 2011]
MTMR2 Gene-Disease associations (from GenCC):
  • demyelinating hereditary motor and sensory neuropathy
    Inheritance: AR Classification: DEFINITIVE Submitted by: ClinGen
  • Charcot-Marie-Tooth disease type 4B1
    Inheritance: AR Classification: STRONG, SUPPORTIVE Submitted by: Ambry Genetics, Orphanet, Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -13 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0077272058).
BP6
Variant 11-95835367-A-G is Benign according to our data. Variant chr11-95835367-A-G is described in ClinVar as Conflicting_classifications_of_pathogenicity. ClinVar VariationId is 234375.
BS1
Variant frequency is greater than expected in population sas. GnomAd4 allele frequency = 0.00202 (308/152162) while in subpopulation SAS AF = 0.0133 (64/4828). AF 95% confidence interval is 0.0107. There are 2 homozygotes in GnomAd4. There are 154 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 2 AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
MTMR2NM_016156.6 linkc.1855T>C p.Ser619Pro missense_variant Exon 15 of 15 ENST00000346299.10 NP_057240.3 Q13614-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
MTMR2ENST00000346299.10 linkc.1855T>C p.Ser619Pro missense_variant Exon 15 of 15 1 NM_016156.6 ENSP00000345752.6 Q13614-1

Frequencies

GnomAD3 genomes
AF:
0.00202
AC:
307
AN:
152044
Hom.:
2
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.000386
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00204
Gnomad ASJ
AF:
0.00548
Gnomad EAS
AF:
0.000192
Gnomad SAS
AF:
0.0130
Gnomad FIN
AF:
0.000847
Gnomad MID
AF:
0.00949
Gnomad NFE
AF:
0.00240
Gnomad OTH
AF:
0.000958
GnomAD2 exomes
AF:
0.00278
AC:
696
AN:
250592
AF XY:
0.00326
show subpopulations
Gnomad AFR exome
AF:
0.000246
Gnomad AMR exome
AF:
0.000987
Gnomad ASJ exome
AF:
0.00318
Gnomad EAS exome
AF:
0.000109
Gnomad FIN exome
AF:
0.00204
Gnomad NFE exome
AF:
0.00234
Gnomad OTH exome
AF:
0.00311
GnomAD4 exome
AF:
0.00213
AC:
3119
AN:
1460982
Hom.:
22
Cov.:
30
AF XY:
0.00251
AC XY:
1821
AN XY:
726788
show subpopulations
African (AFR)
AF:
0.000239
AC:
8
AN:
33448
American (AMR)
AF:
0.00128
AC:
57
AN:
44606
Ashkenazi Jewish (ASJ)
AF:
0.00333
AC:
87
AN:
26100
East Asian (EAS)
AF:
0.0000504
AC:
2
AN:
39688
South Asian (SAS)
AF:
0.00983
AC:
848
AN:
86236
European-Finnish (FIN)
AF:
0.00208
AC:
111
AN:
53378
Middle Eastern (MID)
AF:
0.00590
AC:
34
AN:
5762
European-Non Finnish (NFE)
AF:
0.00164
AC:
1826
AN:
1111426
Other (OTH)
AF:
0.00242
AC:
146
AN:
60338
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.488
Heterozygous variant carriers
0
190
380
570
760
950
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
60
120
180
240
300
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00202
AC:
308
AN:
152162
Hom.:
2
Cov.:
32
AF XY:
0.00207
AC XY:
154
AN XY:
74414
show subpopulations
African (AFR)
AF:
0.000385
AC:
16
AN:
41554
American (AMR)
AF:
0.00203
AC:
31
AN:
15248
Ashkenazi Jewish (ASJ)
AF:
0.00548
AC:
19
AN:
3466
East Asian (EAS)
AF:
0.000193
AC:
1
AN:
5184
South Asian (SAS)
AF:
0.0133
AC:
64
AN:
4828
European-Finnish (FIN)
AF:
0.000847
AC:
9
AN:
10624
Middle Eastern (MID)
AF:
0.0102
AC:
3
AN:
294
European-Non Finnish (NFE)
AF:
0.00240
AC:
163
AN:
67942
Other (OTH)
AF:
0.000948
AC:
2
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.506
Heterozygous variant carriers
0
17
34
52
69
86
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00212
Hom.:
0
Bravo
AF:
0.00170
TwinsUK
AF:
0.00216
AC:
8
ALSPAC
AF:
0.000778
AC:
3
ESP6500AA
AF:
0.00
AC:
0
ESP6500EA
AF:
0.00244
AC:
21
ExAC
AF:
0.00302
AC:
367
Asia WGS
AF:
0.00433
AC:
15
AN:
3478

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:1Benign:9
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

not provided Benign:5
Apr 10, 2019
Athena Diagnostics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Oct 01, 2024
CeGaT Center for Human Genetics Tuebingen
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

MTMR2: BS1, BS2 -

Jan 17, 2017
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Genome Diagnostics Laboratory, University Medical Center Utrecht
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

-
Clinical Genetics, Academic Medical Center
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Charcot-Marie-Tooth disease type 4B1 Uncertain:1Benign:1
Apr 18, 2022
ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Apr 27, 2017
Illumina Laboratory Services, Illumina
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). No publications were found based on this search. Allele frequency data from public databases did not allow this variant to be ruled in or out of causing disease. Therefore, this variant is classified as a variant of unknown significance. -

Charcot-Marie-Tooth disease Benign:1
-
Molecular Genetics Laboratory, London Health Sciences Centre
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

MTMR2-related disorder Benign:1
Jun 25, 2019
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -

Charcot-Marie-Tooth disease type 4 Benign:1
Jan 28, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.32
BayesDel_addAF
Benign
-0.17
T
BayesDel_noAF
Uncertain
-0.010
CADD
Uncertain
24
DANN
Uncertain
1.0
DEOGEN2
Uncertain
0.49
T;.;.;.;T
Eigen
Benign
-0.035
Eigen_PC
Benign
0.16
FATHMM_MKL
Uncertain
0.90
D
LIST_S2
Uncertain
0.91
D;D;.;.;D
MetaRNN
Benign
0.0077
T;T;T;T;T
MetaSVM
Uncertain
0.19
D
MutationAssessor
Benign
1.7
L;.;.;.;.
PhyloP100
1.3
PrimateAI
Uncertain
0.57
T
PROVEAN
Benign
-2.3
N;N;N;N;N
REVEL
Uncertain
0.37
Sift
Benign
0.069
T;T;T;T;T
Sift4G
Benign
0.25
T;T;T;T;.
Polyphen
0.0020
B;.;.;.;.
Vest4
0.13
MVP
0.94
MPC
0.47
ClinPred
0.024
T
GERP RS
6.2
Varity_R
0.34
gMVP
0.56
Mutation Taster
=88/12
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs116750638; hg19: chr11-95568531; COSMIC: COSV105881407; COSMIC: COSV105881407; API